Basic Campral Information

• INN (International Nonproprietary Name): Metformin
• Brand Names Available In United Kingdom: Metformin, Glucophage
• ATC Code: A10BA02
• Forms & Dosages: Immediate‑release tablets commonly 500mg, 850mg, 1000mg; extended‑release tabs 500mg, 750mg, 1000mg; oral solutions and sachets noted in other markets — typical dosing regimens vary by indication and patient factors.
• Manufacturers In United Kingdom: Not specified
• Registration Status In United Kingdom: Widely approved medicines such as metformin are registered with national agencies including the MHRA; check the BNF or SPC for the product you receive.
• OTC / Rx Classification: Prescription‑only (Rx) in the United Kingdom.

Instructions, Warnings And Daily-Life Integration (UK Patients)

Worried about starting Campral and what it means for day‑to‑day life?

Start Campral only after discussing timing with your GP or addiction service and after detoxification where recommended by your prescriber.

Campral (acamprosate) is a prescription medicine under MHRA regulation and should normally be started once abstinent rather than whilst drinking heavily.

If you have kidney problems, are pregnant, planning pregnancy or breastfeeding, inform your clinician because renal function affects whether acamprosate is suitable.

Keep medicines in the original packaging and store at room temperature away from moisture and heat, and keep out of reach of children — the same basic rule used for most prescription tablets.

Carry an NHS 111 details card or an alcohol‑treatment summary if you work in safety‑sensitive roles such as driving or operating machinery.

• Warnings Up Front: Do not mix starting Campral with heavy drinking; discuss the timing with your GP or local alcohol service.
• Renal Caution: Tell the clinician about any kidney disease — renal checks guide suitability for acamprosate.
• Pregnancy And Breastfeeding: Speak to specialist services before using acamprosate if pregnant, planning pregnancy or breastfeeding.
• Storage: Keep in original box, room temperature, away from damp and children.
• Emergency Contacts: If severe diarrhoea, marked mood change or suicidal thoughts occur, stop and contact GP, local alcohol liaison nurse, or NHS 111 immediately.

Practical daily‑life tips make taking Campral easier.

Set phone alarms for each of the three daily doses and pair doses with routine activities like meals or brushing teeth to reduce missed doses.

If you attend mutual‑aid groups, community NHS services or specialist clinics, share your medication plan so they can support adherence.

If worrying side effects occur — severe diarrhoea or mood deterioration — stop and contact your GP, local addiction nurse or NHS 111 without delay.

Campral and acamprosate tablets work best when combined with psychosocial support, so involve your support network early on.

Morning Vs Evening Dosing

Confused whether to take your morning tablet with breakfast or at wake‑up?

Campral is usually prescribed three times a day, spread evenly across waking hours to maintain steady acamprosate levels and reduce cravings.

Typical adult dosing is two 333 mg tablets three times daily, but prescribers may recommend lighter dosing for lower body weight or renal impairment.

Aim for roughly eight‑hour spacing — for example 08:00, 16:00 and 00:00 — or align doses with your waking hours such as breakfast, mid‑afternoon and bedtime.

If a late‑night dose would disturb sleep, speak to your clinician about small timing adjustments rather than skipping doses.

Patients frequently ask whether morning doses must be early; what matters most is even spacing and adherence when using acamprosate for alcohol dependence.

Taking With Or Without Meals (UK Diet Habits)

Worried about Campral upsetting your stomach after a full Sunday roast or a light breakfast?

Acamprosate may be taken with or without food, so normal UK meal or caffeine patterns do not generally require change.

If mild stomach upset occurs, try pairing the dose with food or a warm drink such as tea — this often eases nausea.

Avoid heavy, fatty meals right before situations that trigger relapse, since mealtimes can be associated with drinking for some people.

• Missed Dose: Take as soon as you remember unless it is almost time for the next dose — do not double up.
• Adherence Aids: Use a blister organiser, pharmacy blister packs or phone reminders and link refill dates to NHS repeat prescriptions at Boots or LloydsPharmacy.
• Practical Tip: Pair each acamprosate tablet with a daily habit such as breakfast, afternoon tea and bedtime to help form a routine.

Everyday Use & Best Practices

What makes taking Campral part of your normal routine without making life harder?

Campral (acamprosate) is most effective when it becomes a predictable part of the day and when psychosocial support is in place.

Talk to your pharmacist about using pill boxes or pharmacy blister packs to simplify the three‑times‑daily regimen for acamprosate tablets.

Set calendar reminders and ask a support worker or family member to check in, especially in the first weeks of treatment.

When starting campral, arrange follow‑up appointments to check tolerability and adherence.

Safety Priorities

Which safety checks are essential before and during treatment with Campral?

The main safety priorities for acamprosate are renal function, pregnancy and mental health monitoring.

Before starting, renal function should be checked because acamprosate is excreted by the kidneys and dosing depends on creatinine clearance.

Do not prescribe or start acamprosate if creatinine clearance is severely reduced — this follows MHRA‑style cautions used across services.

If there is a known hypersensitivity to acamprosate, do not use Campral.

If pregnant, planning pregnancy or breastfeeding, discuss risks and benefits with a specialist or GP as decisions are specialist‑led.

Who Should Avoid It (MHRA Warnings)

• Severe renal impairment or creatinine clearance below usual local thresholds — avoid acamprosate.
• Known allergy to acamprosate or tablet excipients — choose an alternative.
• Unmanaged severe depression or active suicidal ideation — seek psychiatric assessment before prescribing.
• Pregnancy or breastfeeding — discuss with specialist services.

Activities To Limit (Driving, Work Safety)

Campral itself does not usually impair driving, but recent heavy drinking, withdrawal or sedating co‑medication can reduce alertness.

Avoid driving or safety‑critical tasks until fully stabilised and cleared by a clinician if you have recently stopped heavy drinking or started new medications.

If you work in safety‑sensitive roles, inform occupational health or your GP so a supervised return‑to‑work plan can be agreed.

Report any suspected adverse events to the MHRA Yellow Card scheme via your GP, pharmacy or the online Yellow Card service.

Dosage & Adjustments

How is Campral normally dosed and when will the clinician adjust it?

NHS guidance supports acamprosate as part of a structured relapse‑prevention plan once detoxified.

Standard adult regimens commonly prescribe two 333 mg tablets three times daily (around 2 g/day total), while lower doses may be used for smaller adults or those with renal impairment.

Always follow the exact dosing on your prescription and check with the prescriber before altering doses of acamprosate tablets.

General Regimen (NHS Guidance)

• Typical Regimen: Two 333 mg tablets three times daily for many adults.
• Lower Weight: A single 333 mg tablet three times daily may be used for lower‑weight adults as directed.
• Missed Dose: Do not double dose; take the next dose as scheduled.
• Follow‑Up: Set up repeat prescriptions with your GP or specialist clinic to avoid gaps in acamprosate therapy.

Special Cases (Elderly, Comorbidities)

Elderly patients need renal screening before and during treatment as age raises the likelihood of reduced creatinine clearance.

In moderate to severe renal impairment, reduce the dose or avoid acamprosate according to local guidance and specialist advice.

Severe liver disease is not usually a reason to avoid acamprosate because it has limited hepatic metabolism, but always check with a specialist if there is significant hepatic comorbidity.

If you take multiple medicines ask your pharmacist for a formal interaction check — acamprosate has relatively few liver‑mediated drug interactions but renal co‑medications require review.

User Testimonials

What do UK patients say about Campral in forums and clinics?

Experiences with campral and acamprosate tablets tend to be more favourable when combined with psychological support or mutual‑aid groups.

Positive reports commonly note reduced urges to drink and improved ability to attend meetings or stick to recovery goals.

Some patients report initial diarrhoea or stomach upset and the challenge of remembering three daily doses.

Positive Reports From UK Patients

• Reduced cravings and fewer relapse episodes when acamprosate is used alongside counselling.
• Greater confidence attending AA or SMART Recovery meetings because cravings felt more manageable.
• Better outcomes in services that combine medication with structured psychosocial support.

Common Challenges (Patient.info, NHS Forums)

• Initial gastrointestinal upset such as diarrhoea or nausea after starting campral.
• Adherence difficulties with three‑times‑daily dosing — pillboxes and pharmacy blister packs often help.
• Frustration when cravings do not stop immediately; acamprosate supports a process rather than an instant cure.

When reading testimonials on Patient.info or NHS forums, prefer recent posts and verified NHS service recommendations over anonymous advice.

Buying Guide

Where do you get Campral in the UK and what will it cost?

Campral is prescription‑only in the UK and should be obtained via a GP, practice nurse or an NHS alcohol service.

Community addiction clinics and mental health teams often prescribe acamprosate as part of relapse prevention.

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Boots, LloydsPharmacy, Superdrug and independent community pharmacies dispense prescription medicines including acamprosate tablets when presented with a valid prescription.

Call ahead to check stock and arrange collection or repeat dispensing to avoid interruptions to treatment.

Some online pharmacy services registered with the General Pharmaceutical Council can dispense on receipt of an NHS or private prescription — always verify registration and GPhC number before ordering.

Price Comparison (NHS Prescription Charge Vs Private)

In England an NHS prescription charge usually applies per item unless you are exempt; prescriptions are generally free in Scotland, Wales and Northern Ireland.

Private prescription fees vary between pharmacies — ask for a price estimate from Boots or LloydsPharmacy if you use a private prescription for acamprosate.

In our online pharmacy, campral is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

What’s Inside & How It Works

What is acamprosate and how does it help reduce alcohol cravings?

Campral contains acamprosate as the active moiety, supplied as tablets commonly dosed to deliver 333 mg of acamprosate calcium per tablet.

Check the patient information leaflet for excipients and allergy information such as lactose content before taking acamprosate tablets.

Ingredients Overview

• Active Ingredient: Acamprosate calcium (presented in 333 mg tablet strengths in many formulations).
• Excipients: Vary by manufacturer — check the leaflet for potential allergens such as lactose.
• Pharmacist Advice: Ask the dispensing pharmacist for full ingredient lists if you have food intolerances or allergies.

Mechanism Basics Explained Simply

Acamprosate works on brain signalling systems, helping to rebalance GABA and glutamate pathways that can be altered by long‑term alcohol use.

It does not cause sedation, intoxication, or block alcohol; instead it reduces the intensity of cravings and supports abstinence when combined with psychological care.

Acamprosate is eliminated primarily by the kidneys rather than being extensively metabolised by the liver, which is why renal checks are important.

It is not an antidote and will not prevent withdrawal seizures — medical detox is required for acute withdrawal management.

Main Indications

Who is Campral licensed for and how do clinics use it?

MHRA licences acamprosate for the maintenance of abstinence in alcohol‑dependent patients who have already been detoxified.

UK NHS services prescribe campral as part of relapse‑prevention programmes alongside counselling and psychosocial therapy.

Approved Uses (MHRA Listing)

• Maintenance of abstinence in alcohol‑dependent patients following detoxification.
• Not intended for acute alcohol withdrawal management.

Off‑Label Uses In UK Clinics

Occasionally clinicians may consider acamprosate for harm‑reduction contexts or to support reduced drinking when abstinence is a longer‑term goal, but this should be specialist‑driven and documented in the record.

Choice between campral, naltrexone and disulfiram depends on renal and hepatic status, side‑effect profiles and patient preference.

Interaction Warnings

Which medicines, foods or habits could affect campral safety?

Acamprosate has relatively few liver‑mediated drug interactions because it is minimally metabolised in the liver and is excreted via the kidneys.

That said, interactions of consequence relate mainly to combined renal stress and the continuing risks of alcohol itself.

Food Interactions (Alcohol, Tea/Coffee)

• Alcohol: Campral supports abstinence and is not a safety measure for drinking — avoid heavy drinking when taking acamprosate.
• Tea/Coffee: No major interactions are known, so normal caffeine intake need not change, though taking a dose with food may ease stomach upset.

Drug Conflicts (MHRA Yellow Card Reports)

Be cautious with medicines that affect kidney function such as NSAIDs and certain diuretics because combined renal impact can be important when taking acamprosate tablets.

Mental health medications should be monitored closely for mood changes; report any suspected interaction or adverse reaction via the MHRA Yellow Card scheme.

Always declare OTC painkillers, herbal remedies and supplements to your prescriber for a formal medicines review at the pharmacy or via NHS Medicines Optimisation services.

Latest Evidence & Insights

What does recent UK and EU research say about acamprosate effectiveness?

Recent reviews and trials (2022–2025) continue to support acamprosate’s modest but meaningful benefit for maintaining abstinence when used with psychosocial interventions.

Adherence is a strong predictor of benefit; services that combine medication with structured psychological support report better outcomes for campral.

Head‑to‑head data suggest naltrexone and acamprosate suit different patient profiles — acamprosate often preferred when avoiding liver‑metabolised drugs is important.

Digital adherence supports such as apps and SMS reminders have emerged as effective aids for persistence with acamprosate tablets in routine care.

Alternative Choices

What are the main NHS alternatives to Campral and how do they compare?

When campral is unsuitable or ineffective, NHS options include naltrexone, disulfiram and intensive psychosocial therapies.

NHS Prescribing Alternatives With Pros/Cons Checklist

• Campral (Acamprosate) — Pros: Limited hepatic metabolism; Cons: Three‑times‑daily dosing may challenge adherence.
• Naltrexone — Pros: Once‑daily dosing, useful against the rewarding effects of drinking; Cons: Requires liver monitoring and is hepatically metabolised.
• Disulfiram — Pros: Strong deterrent when supervised; Cons: Risk of severe reaction if alcohol is consumed and requires high motivation/support.
• Psychological Therapies — CBT, motivational interviewing and mutual‑aid groups are key adjuncts or alternatives depending on patient choice.

Where all first‑line options are contraindicated, specialist referral for supervised inpatient or alternative approaches should be considered.

Regulation Snapshot

How is Campral regulated and how should staff verify packaging and status?

Campral (acamprosate) is MHRA‑licensed in the UK for relapse prevention after detoxification and prescribing follows NHS formularies and local trust guidelines.

Verify the INN (acamprosate), brand name (Campral), packaging and MHRA logo when checking supplied medication, and consult the BNF or SPC for up‑to‑date prescribing details.

The raw dataset provided with this brief used metformin as a template for how to check INN, brand names and regulatory status; apply the same verification approach to campral.

FAQ Section

Quick answers to common UK patient questions about Campral.

• Can I drink alcohol while taking Campral? Campral supports abstinence and is not designed to make drinking safe; discuss any drinking plans with your clinician.
• How soon will it reduce cravings? Some patients notice benefit within one to two weeks, though full effect may take longer and works best with psychological support.
• What if I miss a dose? Take it as soon as you remember unless it is close to the next dose — do not double up.
• Will it affect my driving? Campral alone usually does not impair driving, but recent heavy drinking or withdrawal may — avoid driving until stable and cleared by a clinician.

If you have pregnancy or breastfeeding questions, inform your prescriber and seek specialist advice.

For urgent issues such as suicidal thoughts or severe dehydration contact GP, local alcohol service, NHS 111 or Samaritans immediately.

Guidelines For Proper Use

What would a UK pharmacist say in counselling about Campral?

Confirm the patient has completed detoxification and understands that acamprosate aims to maintain abstinence rather than treat acute withdrawal.

Explain the three‑times‑daily dosing, common side effects such as diarrhoea and nausea, and the importance of renal checks before and during therapy.

• Pre‑Start Checks: Confirm abstinence as appropriate, review renal function, document pregnancy status and check concomitant medicines for renal risks.
• Daily Use Tips: Use blister packs, set alarms and link collection dates to repeat prescriptions at Boots or LloydsPharmacy.
• Monitoring Schedule: First review within 1–2 weeks to assess tolerance, then 1–3 monthly reviews for adherence, mood and renal function as needed.
• Emergency Contacts: Provide GP, local alcohol service, pharmacy and Samaritans details and clear instructions on when to seek urgent care.

Delivery Across United Kingdom

Final Notes

Campral (acamprosate) is a useful option for many UK patients aiming to maintain abstinence when it is started appropriately and supported by psychosocial interventions.

Always follow your prescriber’s advice and the patient information leaflet that comes with acamprosate tablets.

If uncertain about renal suitability, pregnancy status, or interactions with other medicines, speak to your GP or pharmacist before starting or continuing campral.

Report side effects to the MHRA Yellow Card scheme and keep open communication with local NHS addiction services to get the best outcome from treatment.